In vitro, silencing with plasmid DNA-encoding shRNA against MCAM reduced MCAM at mRNA and protein levels for different degrees in different cells, melanoma, endothelial cells, and breast cancer cells, with the highest silencing in melanoma and the lowest in endothelial cells [15,19]. The gene discussed is MCAM; the disease is breast cancer.